Chemistry Wealth Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Chemistry Wealth Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,000	Closed	-$18.7K	–	219
2026 Q1	$18.7K	Hold	12,000	–	–	﹤0.01%	204
2025 Q4	$13.8K	Hold	12,000	–	–	﹤0.01%	200
2025 Q3	$16.2K	Hold	12,000	–	–	﹤0.01%	202
2025 Q2	$11.3K	Hold	12,000	–	–	﹤0.01%	195
2025 Q1	$5.53K	Hold	12,000	–	–	﹤0.01%	184
2024 Q4	$8.86K	Hold	12,000	–	–	﹤0.01%	182
2024 Q3	$18.8K	Hold	12,000	–	–	﹤0.01%	180
2024 Q2	$20.2K	Hold	12,000	–	–	0.01%	167
2024 Q1	$28.8K	Hold	12,000	–	–	0.01%	164
2023 Q4	$18.4K	Hold	12,000	–	–	0.01%	152
2023 Q3	$13.1K	Buy	+12,000	New	+$21.1K	﹤0.01%	146

Other funds holding LXRX

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Chemistry Wealth Management's LXRX Position: Q2 2026 in Review

Chemistry Wealth Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 12,000 shares — an estimated $18.7K sold.

Chemistry Wealth Management first reported a position in LXRX in Q3 2023 and held it in 11 quarters. The position peaked at $28.8K in Q1 2024. 6 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Chemistry Wealth Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Chemistry Wealth Management sold 12,000 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $18.7K.
Chemistry Wealth Management first reported a position in Lexicon Pharmaceuticals in Q3 2023 and held it in 11 quarters.
Chemistry Wealth Management's Lexicon Pharmaceuticals position peaked at $28.8K in Q1 2024.
6 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.